EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tertiary hyperparathyroidism in a patient with autosomal dominant pseudohypoparathyroidism type 1b

Xavier Vandemergel

European Journal of Case Reports in Internal Medicine · 20.11.2026

DOI: 10.12890/2026_007581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Case Reports in Internal Medicine, online erschienen am 20.11.2026. Verfasst von Xavier Vandemergel. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pseudohypoparathyroidism type 1b (PHP1b) is a rare genetic disorder characterized by renal parathyroid hormone (PTH) resistance. While chronic secondary hyperparathyroidism is common, progression to autonomous tertiary hyperparathyroidism remains exceptionally rare, with only five cases reported in the literature. Case description: We report the case of a 66-year-old Caucasian woman with an autosomal dominant form of PHP1b (maternal transmission of a STX16 gene deletion) diagnosed at age 35. After 31 years of stable disease managed with calcitriol, she presented with persistent hypercalcemia for 5 years. Longitudinal follow-up revealed a dramatic, tenfold surge in serum intact PTH levels, peaking at 932 ng/l. Physical examination showed a mildly rounded facies and brain imaging revealed basal ganglia calcifications. A neck ultrasound and technetium-99m sestamibi scintigraphy confirmed a right medial parathyroid nodule. The patient underwent surgical resection of the lesion. Histopathology confirmed a follicular parathyroid adenoma. Postoperatively, serum calcium and PTH levels normalized rapidly and remained stable at 6-month follow-up.

Conclusion

Tertiary hyperparathyroidism is a rare but critical long-term complication of PHP1b that typically occurs after decades of stimulation. In patients with PHP1b, the onset of hypercalcemia accompanied by a significant, progressive increase in PTH levels should immediately raise suspicion of an autonomous parathyroid adenoma and prompt targeted imaging and surgical management.

Zitieren

APA

Vandemergel, X. (2026). Tertiary hyperparathyroidism in a patient with autosomal dominant pseudohypoparathyroidism type 1b. European Journal of Case Reports in Internal Medicine. https://doi.org/10.12890/2026_007581

Vancouver

Vandemergel X. Tertiary hyperparathyroidism in a patient with autosomal dominant pseudohypoparathyroidism type 1b. European Journal of Case Reports in Internal Medicine. 2026. doi:10.12890/2026_007581

BibTeX
@article{Vandemergel2026,
  author = {Vandemergel, Xavier},
  title = {Tertiary hyperparathyroidism in a patient with autosomal dominant pseudohypoparathyroidism type 1b},
  journal = {European Journal of Case Reports in Internal Medicine},
  year = {2026},
  doi = {10.12890/2026_007581}
}
Kostenlos starten →